RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

  • Feature ArticlesFeature Articles

    Regulatory review of advertising on streaming media

    This article discusses advertising on streaming media and what regulatory reviewers need to take into consideration when reviewing online videos.   Introduction Television. One word, many meanings – it could be the wide-screen home TV, the latest Hulu-exclusive series we binge-watch on an iPad, or the 5-minute Snapchat original series that releases a new episode every week. There is no shortage of places for consumers to view video content outside of a traditional ...
  • Feature ArticlesFeature Articles

    Impact of the COVID-19 pandemic on aspects of regulatory advertising and promotion

    This article discusses the impact of the COVID-19 pandemic on aspects of regulatory advertising and promotion. The author discusses how the shift from print to digital promotional strategies has affected certain elements of the regulatory review process and highlights considerations for carrying these learnings forward after the pandemic.   Introduction Almost a year out from the onset of the pandemic, COVID-19 continues to present challenges for regulatory adverti...
  • Feature ArticlesFeature Articles

    Drug Pricing Transparency: The Conversation is Far From Over

    This article discusses the US government’s attempts to require drug pricing transparency in advertising. The authors explain the events following the Centers for Medicare and Medicaid Services (CMS) publication of a proposed rule for regulation to require drug pricing transparency. They outline recent initiatives by a number of other federal agencies to develop ways to inform the public about drug costs, efforts by the Pharmaceutical Research and Manufacturers of America (...